BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3009672)

  • 21. Macrophage antiviral activity: extrinsic versus intrinsic activity.
    Stohlman SA; Woodward JG; Frelinger JA
    Infect Immun; 1982 May; 36(2):672-7. PubMed ID: 6282756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor-2 exacerbates murine acute viral hepatitis.
    Bleau C; Burnette M; Filliol A; Piquet-Pellorce C; Samson M; Lamontagne L
    Immunology; 2016 Oct; 149(2):204-24. PubMed ID: 27273587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
    Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host genetic control of mouse hepatitis virus type 4 (JHM strain) replication. I. Restriction of virus amplification and spread in macrophages from resistant mice.
    Knobler RL; Tunison LA; Oldstone MB
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1543-8. PubMed ID: 6088681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of macrophages and interferon in natural resistance to mouse hepatitis virus infection.
    Virelizier JL
    Curr Top Microbiol Immunol; 1981; 92():53-64. PubMed ID: 6171386
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3.
    Chung S; Li C; Fung LS; Crow A; Gorczynski R; Cole E; Perlman S; Leibowitz J; Levy G
    Adv Exp Med Biol; 1993; 342():377-84. PubMed ID: 8209757
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection.
    Fung LS; Neil G; Leibowitz J; Cole EH; Chung S; Crow A; Levy GA
    J Biol Chem; 1991 Jan; 266(3):1789-95. PubMed ID: 1846363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route.
    Garlinghouse LE; Smith AL
    Lab Anim Sci; 1985 Oct; 35(5):469-72. PubMed ID: 2414512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon-gamma synthesis and macrophage sensitivity to interferon-gamma.
    Lucchiari MA; Martin JP; Modolell M; Pereira CA
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1317-22. PubMed ID: 1646275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration and strain-specificity of immunity to enterotropic mouse hepatitis virus.
    Homberger FR; Barthold SW; Smith AL
    Lab Anim Sci; 1992 Aug; 42(4):347-51. PubMed ID: 1331605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro macrophage manifestation of cortisone-induced decrease in resistance to mouse hepatitis virus.
    Taylor CE; Weiser WY; Bang FB
    J Exp Med; 1981 Mar; 153(3):732-7. PubMed ID: 6265581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1988; 100(3-4):171-83. PubMed ID: 2840871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors involved in the age-dependent resistance of mice infected with low-virulence mouse hepatitis virus.
    Taguchi F; Yamada A; Fujiwara K
    Arch Virol; 1979; 62(4):333-40. PubMed ID: 94538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of 5'-nucleotidase in mouse peritoneal macrophages in listeriosis.
    Pietrangeli CE; Skamene E; Edelson PJ; Kongshavn PA
    Infect Immun; 1981 Jun; 32(3):1206-10. PubMed ID: 6265374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.
    de Souza MS; Smith AL
    Lab Anim Sci; 1991 Apr; 41(2):112-8. PubMed ID: 1658437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of immunologic function among subfractions of normal rat alveolar macrophages. II. Activation as a determinant of functional activity.
    Shellito J; Kaltreider HB
    Am Rev Respir Dis; 1985 May; 131(5):678-83. PubMed ID: 2988384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of viral infections in animal models to assess changes in the immune system.
    Kern ER
    Environ Health Perspect; 1982 Feb; 43():71-9. PubMed ID: 6174323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectoenzyme action on purine nucleotides in macrophages and subsequent reactions.
    Karnovsky ML; Philippeaux MM
    Ann N Y Acad Sci; 1985; 451():250-5. PubMed ID: 3000254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.